Expression of enterotoxigenicEscherichia colicolonization factors inVibrio cholerae

As a first step towards a vaccine against diarrhoeal disease caused by enterotoxigenicEscherichia coli(ETEC), we have studied the expression of several ETEC antigens in the live attenuatedVibrio choleraevaccine strain CVD 103-HgR. Colonization factors (CF) CFA/I, CS3, and CS6 were expressed at the s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2006-05, Vol.24 (20), p.4354
Hauptverfasser: Favre, Didier, Lüdi, Stefan, Stoffel, Michael, Frey, Joachim, Horn, Michael P, Dietrich, Guido, Spreng, Simone, Viret, Jean-François
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:As a first step towards a vaccine against diarrhoeal disease caused by enterotoxigenicEscherichia coli(ETEC), we have studied the expression of several ETEC antigens in the live attenuatedVibrio choleraevaccine strain CVD 103-HgR. Colonization factors (CF) CFA/I, CS3, and CS6 were expressed at the surface ofV. choleraeCVD 103-HgR. Both CFA/I and CS3 required the co-expression of a positive regulator for expression, while CS6 was expressed without regulation. Up-regulation of CF expression inV. choleraewas very efficient, so that high amounts of CFA/I and CS3 similar to those in wild-type ETEC were synthesized from chromosomally integrated CF and positive regulator loci. Increasing either the operon and/or the positive regulator gene dosage resulted in only a small increase in CFA/I and CS3 expression. In contrast, the level of expression of the non-regulated CS6 fimbriae appeared to be more dependent on gene dosage. While CF expression in wild-type ETEC is known to be tightly thermoregulated and medium dependent, it seems to be less stringent inV. cholerae. Finally, co-expression of two or three CFs in the same strain was efficient even under the control of one single regulator gene.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2006.02.052